|        |
|--------|
|        |
|   |

|         |                                                                                                     |
|---------|-----------------------------------------------------------------------------------------------------|
| o  | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |

|                                                                |
|----------------------------------------------------------------|
|                                                                |  |  |
| Delaware                                                       |   | 42-1491350 |
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

|                                                             |
|-------------------------------------------------------------|
|                                                             |  |  |
| Securities registered pursuant to Section 12(b) of the Act: | Common Stock, par value $0.01 |   |
| Name of each exchange on which registered:                  | The Nasdaq Global Market |   |
| Securities registered pursuant to Section 12(g) of the Act: | None |   |

|                                               |
|-----------------------------------------------|
|                                               |  |  |
| Large accelerated filer x                |   | Accelerated filer o |
|                                          |   |   |
| Non-accelerated filer o                  |   | Smaller reporting company o |
| (Do not check if a smaller reporting company) |   |   |

----

----

|               |
|---------------|
|               |  |  |  |
|          |   |   | Page |
| Item 15.      | Exhibits, Financial Statement Schedules | 1 |
| Signatures    | 2 |
| Exhibit Index | 3 |

----

|               |                                            |
|---------------|--------------------------------------------|
| Item 15. | Exhibits and Financial Statement Schedules |

----

|                              |
|------------------------------|
|                              |  |  |
| NEWLINK GENETICS CORPORATION |
|                         |   |   |
| By:                          |   | /s/ Charles J. Link, Jr. |
|                         |   | Charles J. Link, Jr. |
|                         |   | Chief Executive Officer |

|        |
|--------|
|        |  |  |
|   |   |   |
| By:    |   | /s/ John B. Henneman III |
|   |   | John B. Henneman III |
|   |   | Chief Financial Officer And Secretary |

|                           |
|---------------------------|
|                           |  |  |
| Signature                 |
| /s/ Charles J. Link, Jr.  |   | Chief Executive Officer, Chairman of the Board of Directors and Director(Principal Executive Officer) |
| Charles J. Link, Jr.      |   |
|                      |   |   |
| /s/ John B. Henneman, III |   | Chief Financial Officer and Secretary |
| John B. Henneman, III     |   | (Principal Financial Officer) |
|                      |   |   |
| *                         |   | Director |
| Thomas A. Raffin          |   |   |
|                      |   |   |
| *                         |   | Director |
| Ernest J. Talarico, III   |   |   |
|                      |   |   |
| *                         |   | Director |
| Lota Zoth                 |   |   |
|                      |   |   |
| *                         |   | Director |
| Joseph Saluri             |   |   |
|                      |   |   |
| *                         |   | Director |
| Paul Edick                |   |   |
|                      |   |   |
| *                         |   | Director |
| Paolo Pucci               |   |   |
|                      |   |   |
| *                         |   | Director |
| Nicholas N. Vahanian      |   |   |

|        |
|--------|
|        |  |  |
| *By    |   | /s/ Charles J. Link, Jr. |
|   |   | Charles J. Link, Jr. |
|   |   | Attorney-in-Fact |

----

|                |
|----------------|
|                |  |  |  |  |  |  |
|           |   |   | Incorporated By Reference |   |
| Exhibit Number |   | Description | Form | Filing Date | Number | Filed Herewith |
| 3.1            |   | Amended and Restated Certificate of Incorporation filed on November 16, 2011 | 8-K | 11/18/2011 | 3.1 |   |
| 3.2            |   | Certificate of Amendment to Restated Certificate of Incorporation filed on May 10, 2013 | 8-K | 5/14/2013 | 3.1 |   |
| 3.3            |   | Amended and Restated Bylaws | 8-K | 11/18/2011 | 3.2 |   |
| 4.1            |   | Form of the Registrant's Common Stock Certificate | S-1/A | 10/26/2011 | 4.1 |   |
| 4.2            |   | Reference is made to Exhibits 3.1, 3.2 and 3.3 |   |   |   |   |
| 4.3            |   | Amended and Restated Investor Rights Agreement by and between the Company and certain holders of the Company's capital stock dated as of December 1, 2010 | 10-Q | 5/10/2012 | 4.3 |   |
| 10.1           | † | Form of Indemnity Agreement by and between the Registrant and its directors and executive officers | S-1/A | 11/8/2011 | 10.11 |   |
| 10.2           | † | 2000 Equity Incentive Plan | S-1 | 12/21/2010 | 10.2 |   |
| 10.3.1         | † | Form of Stock Option Agreement under 2000 Equity Incentive Plan | S-1 | 12/21/2010 | 10.3 |   |
| 10.3.2         | † | Form of Stock Option Grant Notice under 2000 Equity Incentive Plan | S-1 | 12/21/2010 | 10.4 |   |
| 10.3.3         | † | Form of Stock Bonus Agreement under 2000 Equity Incentive Plan | S-1 | 12/21/2010 | 10.5 |   |
| 10.4           | † | Amended and Restated 2009 Equity Incentive Plan | S-1 | 12/21/2010 | 10.6 |   |
| 10.4.1         | † | Form of Stock Option Agreement under 2009 Equity Incentive Plan | S-1 | 12/21/2010 | 10.7 |   |
| 10.4.2         | † | Form of Stock Option Grant Notice under 2009 Equity Incentive Plan | S-1 | 12/21/2010 | 10.8 |   |
| 10.4.3         | † | Form of Restricted Stock Unit Award Agreement under the 2009 Equity Incentive Plan, as amended | 10-Q | 8/5/2014 | 10.6 |   |
| 10.4.4         | † | Form of Restricted Stock Unit Grant Notice [Four Year Annual Vesting] under the 2009 Equity Incentive Plan, as amended | 10-Q | 8/5/2014 | 10.7 |   |
| 10.4.5         | † | Form of Restricted Stock Unit Grant Notice [Immediately Vested] under the 2009 Equity Incentive Plan, as amended | 10-Q | 8/5/2014 | 10.8 |   |
| 10.5           | † | 2010 Employee Stock Purchase Plan | 8-K | 5/14/2013 | 10.2 |   |
| 10.6           | † | 2010 Non-Employee Directors' Stock Award Plan, as amended | 10-Q | 8/5/2014 | 10.3 |   |
| 10.6.1         | † | Form of Restricted Stock Unit Award Agreement under the 2010 Non-Employee Directors' Stock Award Plan, as amended | 10-Q | 8/5/2014 | 10.4 |   |
| 10.6.2         | † | Form of Restricted Stock Unit Grant Notice under the 2010 Non-Employee Directors' Stock Award Plan, as amended | 10-Q | 8/5/2014 | 10.5 |   |
| 10.7           | * | License Agreement dated July 7, 2005 by and between the Registrant and Lankenau Institute for Medical Research | S-1/A | 11/8/2011 | 10.30 |   |
| 10.7.1         | * | First Amendment to License Agreement dated May 22, 2006 by and between the Registrant and Lankenau Institute for Medical Research | S-1/A | 11/8/2011 | 10.31 |   |
| 10.7.2         | * | Second Amendment to License Agreement September 11, 2007 by and between the Registrant and Lankenau Institute for Medical Research | S-1/A | 11/8/2011 | 10.32 |   |
| 10.8           | * | Exclusive License Agreement executed December 21, 2007 by and between the Registrant and Lankenau Institute for Medical Research | S-1/A | 11/8/2011 | 10.33 |   |
| 10.9           | * | Exclusive License Agreement effective April 23, 2009 by and between the Registrant and Lankenau Institute for Medical Research | S-1/A | 11/8/2011 | 10.34 |   |
| 10.10          | * | License Agreement dated August 2, 2001 by and between the Registrant and Central Iowa Health System | S-1/A | 11/8/2011 | 10.37 |   |
| 10.11          | * | License Agreement dated September 13, 2005 by and between the Registrant and Medical College of Georgia Research Institute, Inc. | S-1/A | 11/8/2011 | 10.46 |   |
| 10.11.1        | * | Amendment to License Agreement dated April 27, 2006 by and between the Registrant and Medical College of Georgia Research Institute, Inc. | S-1/A | 11/8/2011 | 10.47 |   |
| 10.11.2        | * | Amendment to License Agreement dated April 27, 2006 by and between the Registrant and Medical College of Georgia Research Institute, Inc. | S-1/A | 11/8/2011 | 10.48 |   |

----

|         |
|---------|
|         |  |  |  |  |  |  |
| 10.11.3 | * | Amendment to License Agreement dated February 13, 2007 by and between the Registrant and Medical College of Georgia Research Institute, Inc. | S-1/A | 11/8/2011 | 10.49 |   |
| 10.11.4 | * | Amendment to License Agreement dated March 28, 2006 by and between the Company and  Medical College of Georgia Research Institute, Inc. | 10-Q | 11/10/2014 | 10.3 |   |
| 10.11.5 | * | Amendment to License Agreement dated July 10, 2014 by and between the Company and  Medical College of Georgia Research Institute, Inc. | 10-Q | 11/10/2014 | 10.4 |   |
| 10.12   | * | Patent License Agreement dated March 1, 2006 by and between the Registrant and Bresagen Xenograft Marketing Ltd. | S-1/A | 11/8/2011 | 10.50 |   |
| 10.13   | * | Exclusive License Agreement dated July 29, 2008 by and between the Regents of the University of California and BioProtection Systems Corporation | S-1/A | 11/8/2011 | 10.66 |   |
| 10.14   | * | Sole License Agreement executed May 4, 2010 by and between Public Health Agency of Canada in Right of Canada and BioProtection Systems Corporation | S-1/A | 11/8/2011 | 10.67 |   |
| 10.15   |   | Amendment dated July 31, 2014 to the Sole License Agreement by and between BioProtection Systems Corporation and Public Health Agency of Canada in Right of Canada as Represented by the Minister of Health dated May 4, 2010 | 10-Q | 11/10/2014 | 10.5 |   |
| 10.16   | * | Letter of Intent for Cooperative Research and Development Agreement (CRADA #2166) dated May 7, 2007 by and between the Registrant and National Cancer Institute | S-1/A | 11/8/2011 | 10.38 |   |
| 10.16.1 |   | Amendment No. 1 to Letter of Intent for CRADA #2166 dated January 17, 2008 by and between the Registrant and National Cancer Institute | S-1/A | 10/4/2011 | 10.39 |   |
| 10.16.2 |   | Amendment No. 2 to Letter of Intent for CRADA #2166 dated July 7, 2008 by and between the Registrant and National Cancer Institute | S-1/A | 10/4/2011 | 10.40 |   |
| 10.16.3 |   | Amendment No. 3 to Letter of Intent for CRADA #2166 dated March 24, 2009 by and between the Registrant and National Cancer Institute | S-1/A | 10/4/2011 | 10.41 |   |
| 10.16.4 |   | Amendment No. 4 to Letter of Intent for CRADA #2166 dated October 28, 2009 by and between the Registrant and National Cancer Institute | S-1/A | 10/4/2011 | 10.42 |   |
| 10.16.5 |   | Amendment No. 5 to Letter of Intent for CRADA #2166 dated December 16, 2009 by and between the Registrant and National Cancer Institute | S-1/A | 10/4/2011 | 10.43 |   |
| 10.16.6 |   | Amendment No. 6 to Letter of Intent for CRADA #2166 dated June 29, 2010 by and between the Registrant and National Cancer Institute | S-1/A | 10/4/2011 | 10.44 |   |
| 10.16.7 |   | Amendment No. 7 to Letter of Intent for CRADA #2166 dated November 26, 2010 by and between the Registrant and National Cancer Institute | S-1/A | 10/4/2011 | 10.45 |   |
| 10.16.8 |   | Amendment No. 8 to Letter of Intent for CRADA #2166 dated June 2, 2011 by and between the Registrant and National Cancer Institute | S-1/A | 10/4/2011 | 10.79 |   |
| 10.17   |   | Lease dated September 1, 2000 by and between the Registrant and Iowa State University Research Park Corporation | S-1 | 12/21/2010 | 10.46 |   |
| 10.18   |   | Sublease Agreement effective February 1, 2001 by and between the Registrant and Iowa State Innovation System | S-1 | 12/21/2010 | 10.47 |   |
| 10.19   |   | Memorandum of Agreement dated December 6, 2005 by and between the Registrant and Iowa State University Research Park Corporation | S-1 | 12/21/2010 | 10.48 |   |
| 10.20   |   | Memorandum of Agreement dated April 13, 2006 by and between the Registrant and Iowa State University Research Park Corporation | S-1 | 12/21/2010 | 10.49 |   |
| 10.21   |   | Memorandum of Agreement dated February 20, 2008 by and between the Registrant and Iowa State University Research Park Corporation | S-1 | 12/21/2010 | 10.50 |   |
| 10.22   |   | Memorandum of Agreement dated May 1, 2009 by and between the Registrant and Iowa State University Research Park Corporation | S-1 | 12/21/2010 | 10.51 |   |
| 10.23   |   | Memorandum of Agreement dated March 24, 2010 by and between the Registrant and Iowa State University Research Park Corporation | S-1 | 12/21/2010 | 10.52 |   |
| 10.24   |   | Lease dated September 30, 2009 by and between the Registrant and Iowa State University Research Park Corporation | S-1 | 12/21/2010 | 10.53 |   |
| 10.25   |   | Lease dated August 10, 2005 by and between BioProtection Systems Corporation and Iowa State University Research Park Corporation | S-1/A | 10/26/2011 | 10.82 |   |
| 10.26   |   | Memorandum of Agreement dated September 29, 2011 by and between the Registrant and Iowa State University Research Park Corporation | S-1/A | 10/26/2011 | 10.84 |   |

----

|         |
|---------|
|         |  |  |  |  |  |  |
| 10.27   |   | Memorandum of Agreement dated September 29, 2011 by and between BioProtection Systems Corporation and Iowa State University Research Park Corporation | S-1/A | 10/26/2011 | 10.83 |   |
| 10.28   |   | Memorandum of Agreement dated November 14, 2011 by and between NewLink Genetics Corporation and Iowa State University Research Park Corporation | 8-K | 11/18/2011 | 10.1 |   |
| 10.29   |   | Promissory Note executed in 2009 by and between the Registrant and Iowa State University Research Park Corporation | S-1 | 12/21/2010 | 10.54 |   |
| 10.30   |   | Forgivable Loan Agreement dated March 10, 2010 by and between the Registrant and City of Ames, Iowa | S-1 | 12/21/2010 | 10.55 |   |
| 10.31   |   | Iowa Values Fund Agreement dated March 18, 2005 by and between the Registrant and Iowa Department of Economic Development | S-1 | 12/21/2010 | 10.56 |   |
| 10.32   |   | Master Contract dated December 29, 2005 by and between the Registrant and Iowa Department of Economic Development | S-1 | 12/21/2010 | 10.58 |   |
| 10.33   |   | Contract Amendment dated April 21, 2009 between the Registrant and Iowa Department of Economic Development | S-1 | 12/21/2010 | 10.59 |   |
| 10.34   |   | Contract Amendment dated August 19, 2010 between the Registrant and Iowa Department of Economic Development | S-1 | 12/21/2010 | 10.57 |   |
| 10.35   |   | Contract Amendment dated August 19, 2010 between the Registrant and Iowa Department of Economic Development | S-1 | 12/21/2010 | 10.60 |   |
| 10.36   |   | Contract Amendment effective February 17, 2011 between the Registrant and Iowa Department of Economic Development | S-1/A | 9/14/2011 | 10.77 |   |
| 10.37   |   | Contract Amendment effective February 17, 2011 between the Registrant and Iowa Department of Economic Development | S-1/A | 9/14/2011 | 10.78 |   |
| 10.38   |   | Contract No. W911NF-08-C-0044 dated May 5, 2008 by and between BioProtection Systems Corporation and the United States Department of Defense | S-1/A | 2/28/2011 | 10.68 |   |
| 10.38.1 |   | Amendment to Contract No. W911NF-08-C-0044 dated February 12, 2009 by and between BioProtection Systems Corporation and the United States Department of Defense | S-1/A | 2/28/2011 | 10.69 |   |
| 10.39   | * | Contract No. HDTRA1-09-C-0014 dated September 25, 2009 by and between BioProtection Systems Corporation and the United States Department of Defense | S-1/A | 11/8/2011 | 10.70 |   |
| 10.39.1 |   | Amendment of Contract No. HDTRA1-09-C-0014 dated September 20, 2011 by and between BioProtection Systems Corporation and the United States Department of Defense | S-1/A | 10/4/2011 | 10.80 |   |
| 10.40   |   | Contract No. W911NF-09-C-0072 dated July 31, 2009 by and between BioProtection Systems Corporation and the United States Department of Defense | S-1/A | 2/28/2011 | 10.71 |   |
| 10.40.1 |   | Amendment to Contract No. W911NF-09-C-0072 dated April 21, 2010 by and between BioProtection Systems Corporation and the United States Department of Defense | S-1/A | 2/28/2011 | 10.72 |   |
| 10.41   |   | Grant Number 5U01AI066327-05 issued August 26, 2009 by and between BioProtection Systems Corporation and the National Institutes of Health | S-1/A | 2/28/2011 | 10.73 |   |
| 10.42   |   | Grant Number 1R43AI084350-01A1 issued April 6, 2010 by and between BioProtection Systems Corporation and the National Institutes of Health | S-1/A | 2/28/2011 | 10.74 |   |
| 10.43   |   | Grant Number 5R43AI084350-02 issued March 24, 2011 by and between BioProtection Systems Corporation and the National Institutes of Health | S-1/A | 10/4/2011 | 10.81 |   |
| 10.44   |   | NewLink Genetics Corporation 401(k) Prototype Plan and Trust, effective as of January 1, 2005 | 8-K | 3/12/2012 | 10.2 |   |
| 10.45   |   | NewLink Genetics Corporation 401(k) Adoption Agreement, effective as of January 1, 2005 | 8-K | 3/12/2012 | 10.3 |   |
| 10.46   |   | Material Modification to the NewLink Genetics Corporation 401(k) Adoption Agreement, effective as of January 1, 2011 | 8-K | 3/12/2012 | 10.4 |   |
| 10.47   |   | Settlement Agreement with the Iowa Economic Development Authority, effective as of March 26, 2013 | 8-K | 3/28/2012 | 10.1 |   |
| 10.48   | * | Cooperative Research and Development Agreement between the Company and the National Cancer Institute, effective as of March 27, 2012 | 10-Q | 5/10/2012 | 10.6 |   |

----

|         |
|---------|
|         |  |  |  |  |  |  |
| 10.49   |   | Memorandum of Agreement dated May 7, 2012 by and between the Registrant and Iowa State University Research Park Corporation | 10-K | 3/15/2013 | 10.1 |   |
| 10.50   |   | Memorandum of Agreement dated May 7, 2012 by and between BioProtection Systems Corporation and Iowa State University Research Park Corporation | 10-K | 3/15/2013 | 10.2 |   |
| 10.51   |   | Memorandum of Agreement dated November 6, 2012 by and between BioProtection Systems Corporation and Iowa State University Research Park Corporation | 10-K | 3/15/2013 | 10.3 |   |
| 10.52   |   | Memorandum of Agreement dated April 15, 2013 by and between the Registrant and Iowa State University Research Park Corporation | 10-Q | 5/8/2013 | 10.1 |   |
| 10.53   |   | Memorandum of Agreement; Addendum to the Lease Between ISU Research Park Corporation and NewLink Genetics Corporation Dated March 1, 2010 | 10-Q | 8/8/2013 | 10.2 |   |
| 10.54   |   | Amendment of Contract No. HDTRA1-09-C-0014, by and between BioProtection Systems Corporation and the United States Department of Defense, dated as of September 18, 2013 | 10-Q | 11/12/2013 | 10.1 |   |
| 10.55   |   | License Agreement Amendment, by and between NewLink Genetics Corporation and Georgia Health Sciences University Research Institute, dated as of July 13, 2013 | 10-Q | 11/12/2013 | 10.2 |   |
| 10.56   |   | Memorandum of Agreement, dated January 4, 2014, by and between the Registrant and Iowa State University Research Park Corporation | 10-K | 3/12/2014 | 10.93 |   |
| 10.57   | * | Amendment to License Agreement dated December 30, 2013, by and between Registrant and Central Iowa health System | 10-K | 3/12/2014 | 10.94 |   |
| 10.58   | * | Development and Process Transfer Program Leading to Commercial Manufacturing for algenpantucel-L HyperAcute Pancreas by and between the Company and WuXi AppTec, Inc. dated June 19, 2014 | 10-Q | 8/5/2014 | 10.2 |   |
| 10.59   |   | Amendment dated September 30, 2014 to the Development and Manufacturing Terms and Conditions by and between the Company and WuXi AppTec. Inc. dated June 19, 2014 | 10-Q | 11/10/2014 | 10.2 |   |
| 10.60   | * | License and Collaboration Agreement dated October 16, 2014 by and among the Company, NewLink Global, Genentech, Inc. and F. Hoffmann-LaRoche Ltd. | 10-Q | 11/10/2014 | 10.1 |   |
| 10.61   | * | License and Collaboration Agreement dated November 21, 2014 by and among the Company, BioProtection Systems Corporation and Merck Sharp & Dohme Corp. | 10-K | 3/16/2015 | 10.105 |   |
| 10.62   |   | Memorandum of Agreement dated October 25, 2014; Addendum to the Lease Between ISU Research Park Corporation and NewLink Genetics Corporation dated August 22, 2005 | 10-K | 3/16/2015 | 10.106 |   |
| 10.62.1 | t | Memorandum of Agreement dated July 9, 2015; Addendum to the Lease Between ISU Research Park Corporation and NewLink Genetics Corporation dated August 22, 2005 |   |   |   |   |
| 10.63   |   | Memorandum of Agreement dated December 29, 2014; Addendum to the Lease Between ISU Research Park Corporation and NewLink Genetics Corporation dated March 1, 2010 | 10-K | 3/16/2015 | 10.107 |   |
| 10.63.1 |   | Memorandum of Agreement dated February 12, 2015; Addendum to the Lease Between ISU Research Park Corporation and NewLink Genetics Corporation dated March 1, 2010 | 10-K | 3/16/2015 | 10.108 |   |
| 10.63.2 | t | Memorandum of Agreement dated September 21, 2015; Addendum to the Lease Between ISU Research Park Corporation and NewLink Genetics Corporation dated March 1, 2010 |   |   |   |   |
| 10.64   | † | 2014 Bonus Awards | 8-K | 1/6/2015 | 10.1 |   |
| 10.65   | † | 2015 Salaries, Bonus Targets and Equity Awards | 8-K | 1/6/2015 | 10.2 |   |
| 10.66   |   | First Amendment dated March 31, 2015 to the License and Collaboration Agreement by and between the Company, NewLink Global, Genentech, Inc. and F. Hoffmann-La Roche Ltd. dated as of October 16, 2014 | 10-Q | 5/11/2014 | 10.1 |   |
| 10.67   | † | Separation and Release Agreement between the Company and W. Jay Ramsey, dated as of May 22, 2015 | 10-Q | 8/6/2015 | 10.3 |   |
| 10.68   | * | Amended and Restated Development and Manufacturing Terms and Conditions by and between the Company and WuXi AppTec, Inc. dated January 4, 2016 |   |   |   | X |
| 21.1    | t | Subsidiary Information |   |   |   |   |
| 23.1    | t | Consent of KPMG LLP, independent registered public accounting firm |   |   |   |   |
| 24.1    | t | Power of Attorney (included on signature page hereto) |   |   |   |   |

----

|         |
|---------|
|         |  |  |  |  |  |  |
| 31.1    |   | Rule 13a-14(a)/15d-14(a) Certification |   |   |   | X |
| 31.2    |   | Rule 13a-14(a)/15d-14(a) Certification |   |   |   | X |
| 32.1    | # | Section 1350 Certification |   |   |   | X |
| 101.INS | t | XBRL Instance Document (filed electronically herewith) |   |   |   |   |
| 101.SCH | t | XBRL Taxonomy Extension Schema Document (filed electronically herewith) |   |   |   |   |
| 101.CAL | t | XBRL Taxonomy Extension Calculation Linkbase Document (filed electronically herewith) |   |   |   |   |
| 101.LAB | t | XBRL Taxonomy Extension Label Linkbase Document (filed electronically herewith) |   |   |   |   |
| 101.PRE | t | XBRL Taxonomy Extension Presentation Linkbase Document (filed electronically herewith) |   |   |   |   |
| 101.DEF | t | XBRL Taxonomy Extension Definition Linkbase Document (filed electronically herewith) |   |   |   |   |
|    |   |   |   |   |   |   |

|         |
|---------|
|         |  |
| † | Indicates management contract or compensatory plan. |
| *       | Indicates confidential treatment has been requested with respect to specific portions of this exhibit. Omitted portions have been filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 19434, as amended. |
| #       | The certifications attached as Exhibit 32.1 that accompany this Annual Report on Form 10-K are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of NewLink Genetics Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing. |
| t       | Previously filed. |